PSA submission to the Royal Commission into Violence, Abuse, Neglect and Exploitation of People with Disability
The Pharmaceutical Society of Australia (PSA) is pleased to make this submission to the Royal Commission into Violence, Abuse, Neglect and Exploitation of People with Disability (the ‘Royal Commission’) in response to the Issues paper on Health care for people with cognitive disability. For the purpose of the Issues paper, PSA understands “people with cognitive disability” include people with intellectual disability, autism, acquired brain injury or dementia.
